Zobrazeno 1 - 10
of 292
pro vyhledávání: '"van der Putten E"'
Autor:
van der Putten E; Modra Pharmaceuticals B.V., Amsterdam 1083 HN, the Netherlands., Wosikowski K; Modra Pharmaceuticals B.V., Amsterdam 1083 HN, the Netherlands., Beijnen JH; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam 1066 CX, the Netherlands., Imre G; SOLVO Biotechnology, Budapest H-1117, Hungary., Freund CR; Modra Pharmaceuticals B.V., Amsterdam 1083 HN, the Netherlands.
Publikováno v:
Cancer drug resistance (Alhambra, Calif.) [Cancer Drug Resist] 2024 Jan 31; Vol. 7, pp. 3. Date of Electronic Publication: 2024 Jan 31 (Print Publication: 2024).
Publikováno v:
In European Journal of Cancer October 2022 174 Supplement 1:S109-S109
Autor:
Westebring – van der Putten, E. P.1,2 (AUTHOR) E.p.westebring-vanderputten@tudelft.nl, Goossens, R. H. M.1 (AUTHOR), Jakimowicz, J. J.3 (AUTHOR), Dankelman, J.2 (AUTHOR)
Publikováno v:
Minimally Invasive Therapy & Allied Technologies. Feb2008, Vol. 17 Issue 1, p3-16. 14p. 4 Diagrams.
Autor:
Seymour, L., Calvert, AH, Lobbezoo, MW, Eisenhauer, EA, Giaccone, G, Aamdal, SA, Awada, AA, Azab, M, Calvert, Hilary, Eckhardt, S. Gail, Ellis, Lee M., Fowst, CM, Gietema, Jourik A., Kristeleit, S, Marsoni, S, O'Dwyer, Peter J, van der Putten, E, Saeter, G, Schmalix, W, Sessa, CS, Stephens, W, Tabernero, Josep, TOMASZEWSKI, JE, Winkler, JD, Wright, J
Publikováno v:
European Journal of Cancer, 49(8), 1808-1814. ELSEVIER SCI LTD
The Methodology for the Development of Innovative Cancer Therapies (MDICT) task force considered aspects of the design and conduct of early (phase I and II) studies of combinations of molecular targeted agents during their 2012 meeting. The task forc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a2563d3c20dd2414ee845d86de468a
https://research.rug.nl/en/publications/db762d3b-e496-4da7-8af4-5bf1e1268dff
https://research.rug.nl/en/publications/db762d3b-e496-4da7-8af4-5bf1e1268dff
Autor:
Vermunt MAC; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands. m.vermunt@nki.nl., van der Heijden LT; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., Hendrikx JJMA; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., Schinkel AH; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., de Weger VA; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., van der Putten E; Modra Pharmaceuticals BV, Barbara Strozzilaan 201, Amsterdam, 1083HN, The Netherlands., van Triest B; Department of Radiotherapy, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., Bergman AM; Department of Medical Oncology and Oncogenomics, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands., Beijnen JH; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, Amsterdam, 1066CX, The Netherlands.; Modra Pharmaceuticals BV, Barbara Strozzilaan 201, Amsterdam, 1083HN, The Netherlands.; Department of Pharmaceutical Sciences, Utrecht University, Heidelberglaan 100, Utrecht, 3584CX, The Netherlands.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2021 Jun; Vol. 87 (6), pp. 855-869. Date of Electronic Publication: 2021 Mar 20.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pereira, Mariana1,2,3 (AUTHOR), Vale, Nuno1,2,4 (AUTHOR) nunovale@med.up.pt
Publikováno v:
Current Oncology. Oct2024, Vol. 31 Issue 10, p6032-6049. 18p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Aputen, Angelico D.1 (AUTHOR) a.aputen@westernsydney.edu.au, Elias, Maria George1,2 (AUTHOR) kieran.scott@westernsydney.edu.au, Gilbert, Jayne3 (AUTHOR) jayne.gilbert@newcastle.edu.au, Sakoff, Jennette A.3 (AUTHOR) jennette.sakoff@newcastle.edu.au, Gordon, Christopher P.1 (AUTHOR) c.gordon@westernsydney.edu.au, Scott, Kieran F.2,4 (AUTHOR), Aldrich-Wright, Janice R.1 (AUTHOR) j.aldrich-wright@westernsydney.edu.au
Publikováno v:
International Journal of Molecular Sciences. Feb2024, Vol. 25 Issue 4, p2181. 33p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.